Regenerys ^Companies

Regenerys is a regenerative medicine company that develops and sells products for bioprocessing and biostorage. Their main goals are to provide innovative solutions for the treatment of serious burns and difficult to heal wounds, as well as to facilitate better cosmetic outcomes in breast cancer surgery and other cosmetic procedures. Their flagship products include Myskin, which uses cultured allegoneic cells for autologous treatment, and Cryoskin, a medicine for burns using autologous cells. Additionally, Regenerys offers third-party bio-processing and bio-storage services. Since its establishment in 2011, Regenerys has been serving healthcare providers in the UK and Europe.